Articles
Stem cells raise new hopes in heart disease

Stem cells raise new hopes in heart disease

We have all heard a lot about stem cells. Here, pharmaphorum investigates how much we really know and explores their potential in treating heart disease. The use of stem cell treatments, or regenerative medicine, has hit the headlines more than a few times in recent years. This area of research is...

Articles
A history of: Amgen

A history of: Amgen

In the second part of a new series looking at the history of pharma, Robin Walsh takes a look at the origins of the ‘first biotech’ Amgen. Amgen today is the biggest biotechnology company in the world, but its plush headquarters, global reach, and tens of thousands of…

Articles
Smartphones: the new frontier for physicians

Smartphones: the new frontier for physicians

Based on a recent study across Europe and the US, Michelle Kelly suggests that healthcare has to keep an eye on the rapid rise of the smartphone. The pace of new technology hardware is moving at an incredible rate – the question keeping most CEOs awake at night is now…

Sales & Marketing

Sales & Marketing
Solution Spotlight: BrandPRO Biopharma
Sponsored

Solution Spotlight: BrandPRO Biopharma

Strong strategy on paper can unravel when priorities collide. BrandPRO Biopharma gives pharmaceutical teams a place to put their decisions to the test

Digital

Market Access

Editor's Picks

  1. UK budget includes £1bn biopharma investment package
  2. HHS doubles down on controversial peptides plan
  3. Lilly's triple G overpowers Ozempic in diabetes trial
  4. UK puts £100m into "world-first" AI biosecurity facility
  5. US gives $99m for Ebola jab project, as cases spread in Africa

Newsletters and Deep Dive
digital magazine

Oncology

more

Patients

more

R&D

more